Wednesday, September 30, 2015

Neuromod raises $6.2m in Series A

Neuromod said today it raised $6.2 million (EU€5.5 million) in a Series A round of financing, with fund slated to support its mutebutton bi-modal neuromodulation device for patients with chronic tinnitus. Funds from the round came from venture capital firm Fountain Healthcare Partners, the Dublin-based company said. “Neuromod is delighted to announce this investment, which will help us to advance our unique chronic tinnitus treatment technology. As an emerging company we welcome the support and knowledge offered to us from partnering with an experienced international life sciences venture capital fund such as Fountain Healthcare Partners. We are also particularly grateful for the ongoing support we have received from our manufacturing partners, M&M Qualtech and Molex, and from …

from Tinnitus Miracle Book http://ift.tt/1PP7KNu via Get the facts


from Tumblr http://ift.tt/1L5qWa6

No comments:

Post a Comment